| __timestamp | Pharming Group N.V. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4167274 | 94103000 |
| Thursday, January 1, 2015 | 5247851 | 146194000 |
| Friday, January 1, 2016 | 4925118 | 130000 |
| Sunday, January 1, 2017 | 14930297 | 7353000 |
| Monday, January 1, 2018 | 25371768 | 34193000 |
| Tuesday, January 1, 2019 | 23921274 | 56586000 |
| Wednesday, January 1, 2020 | 25338236 | 63382000 |
| Friday, January 1, 2021 | 20182966 | 97049000 |
| Saturday, January 1, 2022 | 17562000 | 139989000 |
| Sunday, January 1, 2023 | 25212000 | 150343000 |
Cracking the code
In the competitive world of biotechnology, cost management is crucial for success. This analysis compares the cost of revenue for two prominent companies: Sarepta Therapeutics, Inc. and Pharming Group N.V. over the past decade. From 2014 to 2023, Sarepta Therapeutics consistently outpaced Pharming Group in terms of cost of revenue, with a peak in 2023 where Sarepta's costs were nearly six times higher than Pharming's. This trend highlights Sarepta's aggressive investment in research and development, a common strategy in the biotech sector to drive innovation and growth. Meanwhile, Pharming Group maintained a more stable cost structure, reflecting a different strategic approach. Understanding these financial dynamics provides valuable insights into each company's operational strategies and market positioning.
Cost of Revenue Trends: Johnson & Johnson vs Sarepta Therapeutics, Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Sarepta Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Sarepta Therapeutics, Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Evotec SE's Expenses
Analyzing Cost of Revenue: Halozyme Therapeutics, Inc. and Pharming Group N.V.
Analyzing Cost of Revenue: Pharming Group N.V. and Alkermes plc
Analyzing Cost of Revenue: Pharming Group N.V. and MiMedx Group, Inc.